Mycronic AB (publ) (LON:0MQG)
492.90
-0.10 (-0.02%)
At close: Feb 20, 2025
Mycronic AB Revenue
In the year 2024, Mycronic AB had annual revenue of 7.06B SEK with 23.68% growth. Mycronic AB had revenue of 2.06B in the quarter ending December 31, 2024, with 4.62% growth.
Revenue
7.06B SEK
Revenue Growth
+23.68%
P/S Ratio
n/a
Revenue / Employee
3.27M SEK
Employees
2,158
Market Cap
3.48B GBP
Revenue Chart
* This company reports financials in SEK.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 7.06B | 1.35B | 23.68% |
Dec 31, 2023 | 5.71B | 587.00M | 11.47% |
Dec 31, 2022 | 5.12B | 484.00M | 10.44% |
Dec 31, 2021 | 4.64B | 753.00M | 19.40% |
Dec 31, 2020 | 3.88B | -425.00M | -9.87% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 43.19B |
Shell | 227.10B |
HSBC Holdings | 48.93B |
Unilever | 50.25B |
Rio Tinto Group | 42.86B |
RELX PLC | 9.43B |
BP p.l.c. | 149.68B |
British American Tobacco p.l.c. | 25.87B |